Coimbatore government medical college to establish separate nursing college this year
COIMBATORE: The Government Medical College and ESI Hospital in Coimbatore is set to establish a separate nursing college this academic year. The hospital has sought permission from the state government to allocate seats for the new college.
Dr M Raveendran, the dean of the Government Medical College and ESI Hospital, said the request includes 100 seats — 60 for BSc Nursing and 40 for Post Basic BSc Nursing, which is available for those who have completed a Diploma in Nursing at the medical college.
Dr Raveendran said, "There has not been any newly established government nursing colleges in Tamil Nadu in the last four years. We have been requesting the government to establish a nursing college at Coimbatore ESI as we have the requisite infrastructure. We expect it to commence this year. Currently, we are managing 100 MBBS and five MD seats at the ESI Medical College."
He said they have a building ready to house the nursing college. "A separate block, which was previously abandoned, was renovated before the Covid-19 pandemic after I took charge as dean. This block helped us accommodate a large number of patients during the pandemic. Once we receive approval for nursing studies, the entire block can be utilised for that purpose. Additionally, we have the necessary faculty in place. When the government allocates seats, it will ensure a minimum level of faculty strength," Dr Raveendran added.
Sources said the campus encompasses 38 acres, including the hospital and the college, which operates with a capacity of 510 beds. Recently, officials from the health department visited the medical college hospital to assess the infrastructure facilities required to support the nursing college.
Unlike regular government hospitals, the ESI Hospital offers only limited services such as emergency care for 48 hours and vaccination. The Government Medical College and ESI Hospital became the first ESI hospital in the country to establish an autopsy facility on its premises. The forensic medicine department began conducting postmortems here on July 22, 2022.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
an hour ago
- India Today
From headache to hospitalization: How seasonal flu has changed post-COVID
In the past, the seasonal flu was considered a bothersome condition that resembled the common cold or "fun flu" and was characterized by minor headaches, a mild fever, some body pains, and exhaustion. Since then, the flu's clinical manifestation and/or intensity have evolved. On the other side of COVID, more people show up in hospitals with what appear to be routine flu-like symptoms that rapidly worsen because of serious respiratory issues. Dr. Pratibha Walde, Consultant - Internal Medicine, Manipal Hospital, Kharadi, Pune explains what has changedOur bodies have changed: The body's reaction to influenza viruses, co-infections, and, of course, the long-term consequences of COVID-19 has been altered by post-pandemic immunological sensitivity. A previously healthy people may develop myocarditis (inflammation of the heart tissue), pneumonia, acute respiratory distress syndrome (ARDS), and in certain situations, multi-organ hospitalisations are on the rise: The most at risk will always be elderly people, children, and those with a history of heart problems, diabetes, or asthma. However, the number of hospitalizations for severe flu-related diseases is increasing, especially among younger people without comorbidities. What usually begins as a sore throat or moderate headache can frequently worsen into a high-grade fever, dyspnea, and chest pain, necessitating oxygen therapy or an admission to the intensive care is also requiring more complex intervetions: The rise in instances requiring the procedure or pleural tapping is one of the most alarming trends we have observed. This entails removing contaminated fluid from the pleural space that envelops the lungs. These situations usually occur when the flu causes substantial pleural effusions or an empyema, which is pus in the pleural space. Large pleural effusions and empyema can cause lung collapse, sepsis, or impairment of lung function if left untreated. The probability of needing mechanical ventilation is further impacted by bruised lungs and postponed treatment, particularly if the infection triggered acute respiratory distress syndrome. With a guarded prognosis, recovery from multi-system failures like ARDS can be Early medical attention is crucial: It is necessary to seek medical attention as soon as possible. It has been shown that antiviral drugs such as oseltamivir (Tamiflu) work best when taken during the first 48 hours of symptoms. While rest, hydration, supportive care, and symptom monitoring are important, it's imperative to get medical help if symptoms initial line of defense is still vaccination: The annual flu shot has a new significance in a world where COVID-19 has changed everything. It is for the public as well as those at risk and the elderly. Vaccination can reduce the need for invasive operations and hospital stays when combined with early detection and medical treatment. Seasonal flu is more than just "the flu" these days. The clinical course is more severe and less predictable. Early symptom detection and timely medical evaluation could make the difference between a full recovery and an extended hospital to India Today Magazine
News18
3 hours ago
- News18
All About The New COVID-19 Variant Causing 'Razor Blade' Sore Throats
Last Updated: The new variant called the NB.1.8.1 has been detected in the US among travellers coming in from Western Pacific nations, with a rising number of patients. The recent spike in coronavirus cases in certain parts of the world has been attributed to a new variant of the virus that caused a global health pandemic, nicknamed the 'razor blade throat" COVID. The variant is called the NB.1.8.1 or 'Nimbus' and causes painful sore throats among those who come into contact. The symptom has been discovered by scientists in India and the United Kingdom, apart from other parts of the world, according to various media outlets. Just when the world was beginning to move on from the horrors of the global health emergency, coronavirus has sprung back into news and discussions with a rising number of affected persons by the new variant. Fever, chills, cough, shortness of breath and loss of taste or smell are proven symptoms of any COVID variant, but Nimbus especially attacks one's throat. While health experts suggest there isn't a cause for major worries about this form of COVID, here is what you need to know about the variant responsible for the sudden spike in global cases. According to a statement dated May 28 by the World Health Organisation, the variant causing the 'razor blade throat' has been spreading primarily in the eastern Mediterranean, Southeast Asia and western Pacific regions. The new variant is responsible for nearly 11% of the global sequenced samples reported since May. In the United States, airport screening held in California, Washington state, Virginia and New York found travellers coming in from those regions affected by the new variant. The new variant is unlikely to cause any worse damage than other variants of the virus that emerged from China in December 2019. Even though Western Pacific countries have reported an increasing number of cases and persons hospitalised, the WHO says there is no proof to suggest the Nimbus variant comes with a disease and symptoms more dangerous than other variants. Likewise, the vaccines proven effective against those variants will help provide relief against NB.1.8.1 as well. The WHO has marked the public health risk from the new variant at a low level, designating it as a 'variant under monitoring" with current vaccinations remaining effective. Last month, Robert F Kennedy Jr announced that COVID-19 injection shots are no longer recommended for healthy children and women undergoing pregnancy. But public health experts raised an immediate question mark on the claim made by the US Health Secretary. First Published: June 22, 2025, 12:37 IST
Time of India
3 hours ago
- Time of India
Maharashtra reports 37 new COVID-19 cases
Mumbai: Maharashtra recorded 37 new coronavirus positive cases on Saturday, taking its overall infection count since January this year to 2,318, the health department said. No fresh fatality linked to the disease has been reported since Thursday. Of the new cases, 19 are in Mumbai, seven in Pune, five in Nagpur, two in Thane city and one each in Panvel, Sangli city as well the district's rural parts, and Akola city, an official statement said. The health department has conducted 25,199 COVID-19 tests across the state since January this year, it said, adding a total of 1,962 patients have recovered so far. Mumbai has reported 942 infection cases this year, including 501 in June and 435 in May, it said. Thirty-two patients have succumbed to the infection in the state since January, of whom 31 had comorbidities and one was suffering from other diseases. PTI>
